Join us at the National Conference & Gluten-Free EXPO May 5 – May 6.  Purchase Tickets NOW!

Accelerating diagnosis, treatments, and a cure for celiac disease and non-celiac gluten sensitivity through research, education, and advocacy.

Digestive Disease National Coalition Public Policy Forum Advocates for Increased Funding for the National Institutes of Health

As part of the Celiac Disease Foundation’s expanding effort to give voice to the celiac disease community in important areas of healthcare policy and federal funding for disease research, Laura Boone, Celiac Disease Foundation Development Manager and Alana Broe, Celiac Disease Foundation Legislative Analyst, attended the Digestive Disease National Coalition (DDNC) Public Policy Forum held […]

The Relationship Between Child Mortality Rates and the Prevalence of Celiac Disease

In recent years, there has been a marked increase in the number of people diagnosed with celiac disease around the world. This pattern suggests that a greater percentage of the population is afflicted than was previously believed. Meanwhile, the rate of child mortality has been decreasing. This is particularly obvious in developing countries where mortality […]

Gluten-Free Diet and Quality of Life

Currently, the only effective treatment for celiac disease is a strict, gluten-free diet for life. Studies have shown that patients who take their diet very seriously not only reduce their risk of long-term health complications, including cancers and bone deterioration, but also tend to be free from stomach and intestinal discomfort. We know that there […]

National Health Council Conference Emphasizes Importance of Patient Voice in Quality Measures

In an effort to give voice to the celiac disease community in important areas of healthcare reform, on February 15, 2018, Alana Broe, the Celiac Disease Foundation’s Legislative Analyst, attended the National Health Council (NHC) Conference: Ensuring the Patient Voice in Quality. This educational program connected patients, disease advocacy organizations, and quality measuring organizations to […]

The Celiac Disease Foundation Submits Comment to FDA on Draft Guidance Regarding Gluten in Medications

On December 12, 2017, the Food & Drug Administration (FDA) issued guidance to drug manufacturers to voluntarily label medications that do not contain gluten with the following statement: “Contains no ingredient made from a gluten-containing grain (wheat, barley, or rye).” The FDA granted a 60 day period to submit comments and suggestions regarding this draft […]

Proud Sponsors of Celiac Disease Foundation